Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: A study in familial combined hyperlipidemia

Atherosclerosis

Volumn 153, Issue 2, 2000, Pages 483-490

  Demacker, Pierre N M ^a   Veerkamp, Mario J ^a   Bredie, Sebastian J H ^a   Marcovina, Santica M ^b   De Graaf, Jacqueline ^a   Stalenhoef, Anton F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apolipoprotein B; Coronary heart disease; Familial combined hyperlipidemia

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FAMILIAL HYPERLIPEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; APOLIPOPROTEINS B; BIOLOGICAL ASSAY; CORONARY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPIDS; MALE; RISK FACTORS;

EID: 0034515791     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00432-9     Document Type: Article

References (35)

1. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: Executive summary
2. National Education Program recommendations for triglyceride measurement: Executive summary
3. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: Executive summary
4. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge
5. Low density lipoprotein subclass patterns and risk of myocardial infarction
6. Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density lipoproteins)
7. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary heart disease in male patients examined by angiography
8. Apoproteins and lipids as discriminators of severity of coronary heart disease
9. Discriminative value of lipids and apoproteins in coronary heart disease
10. Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease
11. Measurement of apoproteins: Time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemia
12. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
13. Inherited susceptibility determines the distribution of dense low density lipoprotein subfraction profile in familial combined hyperlipidemia
14. Segregation analysis of plasma apolipoprotein-B levels in familial combined hyperlipidemia
15. Relation of high-density lipoprotein and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience): Prospective Cardiovascular Munster study
16. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein
17. Evaluation of the dual precipitation method by comparison with the ultracentrifugation method for measurement of lipoproteins in serum
18. Immunonephelometry assay of human apolipoprotein A-1
19. Protein measurement with the Folin phenol reagent
20. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-1 and B. IV. Comparability of apolipoprotein B values by use of international reference material
21. Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions
22. Low density lipoprotein subfractions and the relationship to other risk factors for coronary artery disease in healthy individuals
23. Both inherited susceptibility and enviromental exposure determine the low density lipoprotein subfraction pattern distribution in healthy Dutch families
24. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-1 and B. III. Comparability of apo A-I values by use of international reference material
25. Intra-individual variation of serum cholesterol, triglycerides, and high density lipoprotein cholesterol in normal humans
26. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia
27. Simultaneous measurement of apolipoprotein B turnover in very low and low density lipoproteins in familial hypercholesterolemia
28. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein B kinetics in man: Normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia
29. Low density lipoprotein metabolism in familial combined hyperlipidemia: Mechanism of the multiple lipoprotein phenotypic expression
30. Serum concentrations of apolipoprotein A-1, apolipoprotein B, and lipoprotein (a) in a population sample
31. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: Results from the Framingham Offspring Study
32. Plasma apolipoproteins A-1 and B in survivors of myocardial infarction and in a control group
33. On the presumed inaccuracy of the Friedewald formula in hypertriglyceridemic plasma: A role for imprecise analysis?
34. Testing the accuracy of total cholesterol assays in an external quality control program: Effect of adding sucrose to lyophilized control sera compared with use of fresh or frozen sera